Drug Shortage Report for TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP

Last updated on 2025-08-16 History
Report ID 264477
Drug Identification Number 01977563
Brand name TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP
Common or Proper name TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging size 10 VIALS X 5 ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2025-08-05
Estimated end date 2025-08-29
Actual end date 2025-08-15
Shortage status Resolved
Updated date 2025-08-16
Company comments Inventory remains available at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-08-16 English Compare
v4 2025-08-15 French Compare
v3 2025-08-15 English Compare
v2 2025-08-07 French Compare
v1 2025-08-07 English Compare

Showing 1 to 5 of 5